Background Diabetic retinopathy (DR) is a leading cause of vision loss in the working-age
population worldwide. Many observational and preclinical studies have implicated vascular …

Background Postoperative vitreous cavity haemorrhage (POVCH) is a significant
complication following vitrectomy for proliferative diabetic retinopathy (PDR). It delays visual …

Purpose: To systematically review and perform meta-analysis on the available randomized
controlled trial data for anti-vascular endothelial growth factor (anti-VEGF) agents in the …

Diabetes mellitus is a major cause of avoidable blindness in both the develo** and the
developed countries. Significant technological advances have taken place to improve the …

OBJECTIVE: To assess the effects of preoperative and intraoperative intravitreal
bevacizumab (IVB) injection on the incidence of postoperative vitreous hemorrhage (VH) …

Aims To examine possible benefits of intravitreal bevacizumab (IVB) pretreatment in
vitrectomy for severe diabetic retinopathy. Methods A comprehensive literature search was …

Materials and methods This study identified the patients who underwent vitrectomy from
January 2007 to December 2009 because of diabetes-related complications in South East …

Background/aims To evaluate the efficacy of antivascular endothelial growth factor (anti-
VEGF) agents pretreatment before vitrectomy for patients with complicated proliferative …

The late complications of proliferative diabetic retinopathy (PDR) comprise vitreous
haemorrhage, tractional retinal detachment, combined tractional–rhegmatogenous retinal …

PURPOSE: To compare safety and functional outcomes of vitrectomy with or without
preoperative intravitreal bevacizumab (IVB) for proliferative diabetic retinopathy (PDR) …